What is NDC 83209-220?

83209-220 is the product NDC for Lithium Carbonate, Lithium carbonate 150 mg/1 capsule, listed with the FDA by Boswell Pharmacy Services LLC d/b/a BPS Wholesale. It has 5 package NDCs, shown above in 10- and 11-digit form.

Boswell Pharmacy Services LLC d/b/a BPS Wholesale, NDC labeler code 83209. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lithium Carbonate?

62 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lithium Carbonate NDC 83209-220 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83209-220Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83209-0220Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
83209-220-06	83209022006	6 CAPSULE in 1 BLISTER PACK (83209-220-06)Marketed from Aug 21, 2024
83209-220-15	83209022015	15 CAPSULE in 1 BLISTER PACK (83209-220-15)Marketed from Aug 21, 2024
83209-220-20	83209022020	20 CAPSULE in 1 BLISTER PACK (83209-220-20)Marketed from Aug 21, 2024
83209-220-30	83209022030	30 CAPSULE in 1 BLISTER PACK (83209-220-30)Marketed from Aug 21, 2024
83209-220-60	83209022060	60 CAPSULE in 1 BLISTER PACK (83209-220-60)Marketed from Aug 21, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lithium Carbonate
Generic name (nonproprietary): lithium carbonate
Active ingredients: Lithium carbonate — 150 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Boswell Pharmacy Services LLC d/b/a BPS WholesaleNDC labeler code 83209
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079139
Marketing start: Aug 21, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 83209-220_2033aaf7-d874-b7af-e063-6294a90ab0cfSPL ID 2033aaf7-d874-b7af-e063-6294a90ab0cfSPL set ID 203386e3-718f-7c84-e063-6394a90aed34RxCUI 311355UNII 2BMD2GNA4V
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483209022006 followed by a unit qualifier and the quantity

Package 83209-0220-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: • Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )] • Maintenance treatment in patients 7 years and older [see Clinical Studies (14)] Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: • Treatment of acute manic and mixed episodes in patients 7 years and older ( 1 ) • Maintenance treatment in patients 7 years and older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83209-220

What is NDC 83209-220?: 83209-220 is the product NDC for Lithium Carbonate, Lithium carbonate 150 mg/1 capsule, listed with the FDA by Boswell Pharmacy Services LLC d/b/a BPS Wholesale. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lithium Carbonate.
What is the active ingredient?: Lithium carbonate.
Who is the labeler?: Boswell Pharmacy Services LLC d/b/a BPS Wholesale, NDC labeler code 83209. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lithium Carbonate?: 62 other product NDCs are listed under this name. See all Lithium Carbonate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lithium Carbonate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lithium Carbonate	Lithium carbonate 150 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0887	00054-0887-25
Lithium Carbonate	Lithium carbonate 300 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0890	00054-0890-2500054-0890-31
Lithium Carbonate	Lithium carbonate 300 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0886	00054-0886-2500054-0886-31
Lithium Carbonate	Lithium carbonate 600 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0891	00054-0891-25
lithium carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-1690	67046-1690-03
Lithium Carbonate	Lithium carbonate 450 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4678	70518-4678-00
Lithium Carbonate	Lithium carbonate 600 mg/1	CapsuleOral	American Health Packaging	60687-964	60687-0964-21
Lithium Carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-0547	67046-0547-03
lithium carbonate	Lithium carbonate 150 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4627	70518-4627-00
Lithium Carbonate	Lithium carbonate 300 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1575	67046-1575-03

All 63 Lithium Carbonate NDCs

Other NDCs under ANDA 079139

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 079139
Product	Strength	Form · route	Labeler	Product NDC
Lithium Carbonate	Lithium carbonate 150 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-3565
Lithium Carbonate	Lithium carbonate 300 mg/1	CapsuleOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8480
Lithium Carbonate	Lithium carbonate 300 mg/1	CapsuleOral	American Health Packaging	60687-806
Lithium Carbonate	Lithium carbonate 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0668
Lithium Carbonate	Lithium carbonate 300 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1006
Lithium Carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-0547
Lithium Carbonate	Lithium carbonate 600 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-2312
Lithium Carbonate	Lithium carbonate 300 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-221
Lithium Carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-220
Lithium Carbonate	Lithium carbonate 600 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-222
Lithium Carbonate	Lithium carbonate 600 mg/1	CapsuleOral	American Health Packaging	60687-964